Page 3 - Guidelines Panel News Today

We, a group of medical professionals, researchers, patient representatives, and politicians, call for the UK government to commit to a reversal in the rate of prescribing of antidepressants. Over the past decade, antidepressant prescriptions have almost doubled in England, rising from 47.3 million in 2011 to 85.6 million in 2022-23. Over 8.6 million adults in England are now prescribed them annually (nearly 20% of adults),1 with prescriptions set to rise over the next decade. In addition, the av...

Four inmates who sued an Arkansas jail for giving them ivermectin, an anti-parasitic drug not approved for treating Covid-19, without their consent have settled the lawsuit for $2,000 each, according to the American Civil Liberties Union (ACLU) of Arkansas. Photo by Pietro Jeng on Pexels.com The inmates said they were told they were receiving vitamins,…

In this Viewpoint, the authors summarize the therapeutic landscape for COVID-19, discuss who is most likely to benefit from treatment, provide an update on mana

Technological advances promise to elevate telemedicine to a new level with interactive data visualization.

Technological advances promise to elevate telemedicine to a new level with interactive data visualization

A longtime faculty member at the medical school is being threatened with termination after interviews he gave to CNN and The New York Times. A Mayo Clinic medical school department chair, in a letter a free speech group shared online, threatened to fire a professor after a CNN interview in which he criticized the National Institutes of Health for not backing a COVID-19 treatment and after a New York Times interview where he suggested testosterone improves athletic performance.

13.02.2023 - Immunocompromised Individuals, Including Organ Transplant Recipients, Are at Increased Risk of Severe COVID-19 and Poor Clinical Outcomes SARS-CoV-2 has Mutated to Evade the Formerly EUA-Approved Monoclonal Antibody Therapies and Preventatives ... Seite 1

12.12.2022 - Immunocompromised Individuals, Including Organ Transplant Recipients, are at Increased Risk of Severe COVID-19 and Poor Clinical Outcomes SARS-CoV-2 has Mutated to Evade the Existing EUA-Approved Therapeutic Monoclonal Antibody Therapies CHATHAM, ... Seite 1

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

The U.S. Food and Drug Administration (FDA) says a drug called ivermectin does not work against COVID-19 but ...